| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |